First National Bank Of Omaha Abbott Laboratories Transaction History

First National Bank Of Omaha

$1.48 Billion
Q3 2024

A detailed history of First National Bank Of Omaha transactions in Abbott Laboratories stock. As of the latest transaction made, First National Bank Of Omaha holds 193,931 shares of ABT stock, worth $21.8 Million. This represents 1.5% of its overall portfolio holdings.

Number of Shares

193,931

Previous 188,248 3.02%

Holding current value

$21.8 Million

Previous $19.6 Million 13.04%

% of portfolio

1.5%

Previous 1.36%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$100.07 - $118.13 $568,697 - $671,332	5,683 Added 3.02%	193,931 $22.1 Million
Q2 2024 Aug 15, 2024	SELL	$100.73 - $112.44 $211,533 - $236,124	-2,100 Reduced 1.1%	188,248 $19.6 Million
Q1 2024 May 10, 2024	SELL	$109.52 - $120.96 $1.19 Million - $1.31 Million	-10,861 Reduced 5.4%	190,348 $21.6 Million
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $492,076 - $602,342	-5,456 Reduced 2.64%	201,209 $22.1 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $1.43 Million - $1.71 Million	-14,951 Reduced 6.75%	206,665 $20 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $2.16 Million - $2.41 Million	21,441 Added 10.71%	221,616 $24.2 Million
Q1 2023 May 03, 2023	BUY	$96.86 - $114.01 $5.43 Million - $6.39 Million	56,066 Added 38.91%	200,175 $20.3 Million
Q4 2022 Feb 08, 2023	SELL	$95.06 - $111.52 $863,715 - $1.01 Million	-9,086 Reduced 5.93%	144,109 $15.8 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $556,660 - $644,508	-5,753 Reduced 3.62%	153,195 $14.8 Million
Q2 2022 Sep 06, 2022	BUY	$102.07 - $123.37 $583,738 - $705,553	5,719 Added 3.73%	158,948 $17.3 Million
Q1 2022 May 25, 2022	SELL	$114.02 - $139.04 $470,104 - $573,261	-4,123 Reduced 2.62%	153,229 $18.1 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $635,183 - $777,747	-5,498 Reduced 3.38%	157,352 $22.1 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $3.54 Million - $3.91 Million	30,307 Added 22.87%	162,850 $19.2 Million
Q1 2021 May 06, 2021	BUY	$108.84 - $128.23 $3.99 Million - $4.7 Million	36,617 Added 38.17%	132,543 $15.9 Million
Q4 2020 Feb 18, 2021	BUY	$105.0 - $114.42 $47,880 - $52,175	456 Added 0.48%	95,926 $10.5 Million
Q3 2020 Nov 06, 2020	SELL	$91.64 - $111.29 $1,924 - $2,337	-21 Reduced 0.02%	95,470 $10.4 Million
Q2 2020 Aug 05, 2020	SELL	$76.57 - $98.0 $46,707 - $59,780	-610 Reduced 0.63%	95,491 $8.73 Million
Q1 2020 Apr 29, 2020	SELL	$62.82 - $91.86 $129,723 - $189,690	-2,065 Reduced 2.1%	96,101 $7.58 Million
Q4 2019 Jan 17, 2020	SELL	$78.51 - $87.4 $193,056 - $214,916	-2,459 Reduced 2.44%	98,166 $8.53 Million
Q3 2019 Nov 04, 2019	SELL	$81.84 - $88.74 $187,168 - $202,948	-2,287 Reduced 2.22%	100,625 $8.42 Million
Q2 2019 Jul 10, 2019	SELL	$72.88 - $85.0 $112,162 - $130,815	-1,539 Reduced 1.47%	102,912 $8.66 Million
Q1 2019 May 01, 2019	BUY	$66.22 - $80.06 $157,073 - $189,902	2,372 Added 2.32%	104,451 $8.35 Million
Q4 2018 Jan 23, 2019	BUY	$65.56 - $74.27 $6.69 Million - $7.58 Million	102,079 New	102,079 $7.38 Million
Q4 2018 Jan 22, 2019	SELL	$65.56 - $74.27 $6.52 Million - $7.39 Million	-99,476 Closed	0 $0
Q3 2018 Nov 05, 2018	SELL	$60.81 - $73.36 $55,276 - $66,684	-909 Reduced 0.91%	99,476 $7.3 Million
Q2 2018 Jul 12, 2018	SELL	$57.57 - $63.54 $256,877 - $283,515	-4,462 Reduced 4.26%	100,385 $6.12 Million
Q1 2018 May 03, 2018	BUY	$56.27 - $63.62 $28,753 - $32,509	511 Added 0.49%	104,847 $6.28 Million
Q4 2017 Feb 05, 2018	BUY	$53.68 - $57.47 $5.6 Million - $6 Million	104,336	104,336 $5.95 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Bank Of Omaha, based on Form 13F filings with the SEC.

News

Stay updated on First National Bank Of Omaha with notifications on news.

Account

First National Bank Of Omaha Abbott Laboratories Transaction History